logo of the vendor
Pharma Intelligence UK Ltd logo

Developing innovative treatments for CNS disorders

thumbnail of content

Transforming patient outcomes

The CNS therapeutic solutions market is witnessing huge growth, due to the aging global population and a surge in R&D. But it's not all plain sailing - in order to improve patient outcomes, researchers, stakeholders and regulatory bodies must address a range of complex challenges posed by these neurological and psychiatric disorders.

Delve into this eBook to gain invaluable insight across a myriad of topics, with articles including:

  • Role of Digital Therapeutics in Central Nervous System Clinical Trials
  • For Psychedelics, US FDA Is Open To Creative Thinking But Firm On Approval Standards
  • Schizophrenia, Depression And Neuropathy: What’s Coming In 2024
  • CGT Is In Its Infancy For CNS Disorders, But Technical Strides Being Made
  • Pioneering Partnerships And Novel Trial Design Are Reshaping Repurposing In The CNS Space

Download the Ebook

Opt In?

Please complete all required fields to access the content!

Explore similar content

IQVIA
Pharma Intelligence UK Ltd

Future-Ready Pharmacovigilance: Integrating AI With FDA's EDSTP Guidelines

Join IQVIA’s esteemed panel of experts for an in-depth discussion on how AI can meet and exceed these new expectations. This webinar delves into the intersection of regulatory frameworks and technological innovation, offering insights into the future of PV and how organizations can navigate this transformative field. Key takeaways include:
Webinar Clinical Studies Pharmaceutical Research and Development
ThermoFisher
Pharma Intelligence UK Ltd

Accelerating Biologics Development With Strategies For Success

The biologics market is growing rapidly, unlocking exciting opportunities but also presenting significant challenges. Developers are undergoing pressure to accelerate the delivery of innovative therapies while addressing complex regulatory demands, navigating demanding clinical trial phases, efficiently scaling production, and maintaining quality. In this webinar, industry experts will share practical strategies and real-world examples to help you navigate these challenges. Key takeaways:
Webinar Clinical Studies Pharmaceutical Research and Development
IQVIA Technologies
Pharma Intelligence UK Ltd

A New Era of Participant Payment Services

Financial burdens are cited as one of the main barriers to clinical trial recruitment and retention, with traditional methods proving unreliable, complicated and slow. For trial sites and sponsors, the administration burden can be overwhelming, especially on a global scale. Discover how IQVIA’s Participant Payment service is transforming the participant payment landscape, simplifying the process and driving clinical trial success, by offering:
Article Clinical Studies Pharmaceutical Research and Development